Research Article

MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma

Figure 2

Comparison of MXRA5 mRNA expression levels in CGGA and TCGA cohorts with different WHO grades (a, c) and IDH mutation statuses (b, d). MXRA5 was significantly increased in WHO IV and IDH wild-type gliomas in the CGGA and TCGA datasets. , , and indicate , , and , respectively.